Previous 10 | Next 10 |
2023-08-01 21:20:23 ET Exact Sciences Corporation (EXAS) Q2 2023 Earnings Call Transcript August 01 2023, 05:00 PM ET Company Participants Megan Jones - Vice President of Investor Relations Kevin Conroy - Chairman and Chief Executive Officer Jeff Elliott - Chief ...
2023-08-01 16:20:03 ET Exact Sciences press release ( NASDAQ: EXAS ): Q2 GAAP EPS of -$0.45 beats by $0.06 . Revenue of $622.1M (+19.3% Y/Y) beats by $20.97M . Core revenue was $617.5 million, an increase of 24 percent Screening revenue was $462.8 million, ...
Exact Sciences Announces Second-Quarter 2023 Results PR Newswire Reports record results, generates positive free cash flow, raises full-year guidance Second -quarter 2023 highlights Total second quarter revenue of $622 million , an increase of 19%, and $6...
2023-07-31 17:35:54 ET Exact Sciences ( NASDAQ: EXAS ) is scheduled to announce Q2 earnings results on Tuesday, August 1st, after market close. The consensus EPS Estimate is -$0.41 (vs. -$0.94 last year) and the consensus Revenue Estimate is $601.13M (+15.2% Y/Y). Over...
2023-07-26 07:00:00 ET Summary Baron Health Care Fund invests in companies engaged in the research, development, production, sale, delivery, or distribution of products and services related to the healthcare industry. In the quarter ended June 30, 2023, Baron Health Care Fund adva...
2023-07-23 12:16:48 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips With technology advancing at a breakneck speed, investors – having taken care of their core portfolio needs – should consider must-know growth stocks with their discretionary ...
2023-07-22 08:45:00 ET Investing in companies at the forefront of innovation can be exciting, especially in the healthcare sector. Until we can completely eradicate illnesses, there will always be a market for newer and better ways to offer cutting-edge medical care. And corporations that s...
2023-07-19 13:57:09 ET Summary Exact Sciences, specializing in advanced cancer diagnostics, is recognized for its cutting-edge tests facilitating early cancer detection. 2022 saw significant milestones, testing over 12 million individuals and broadening its global healthcare netwo...
2023-07-19 01:15:36 ET Summary ARK Invest's 13F portfolio value increased by approximately 4% from $14.55B to $15.10B in Q2 2023, with holdings increasing from 221 to 222. The firm established a new 0.69% stake in Palantir Technologies while increasing stakes in Coinbase Global, U...
2023-07-18 09:50:16 ET Cathie Wood is one of the most successful investors of our time. Her flagship fund, Ark Innovation ETF (NYSEMKT: ARKK) , has already delivered a market-beating 59% return on capital so far this year. At its peak less than two years ago, the fund was up by over...
News, Short Squeeze, Breakout and More Instantly...
Exact Sciences Corporation Company Name:
EXAS Stock Symbol:
NASDAQ Market:
Exact Sciences Corporation Website:
2024-07-11 08:28:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-07-08 08:30:00 ET To say that Exact Sciences (NASDAQ: EXAS) hasn't performed well on the stock market this year would be an understatement. Shares of the cancer-focused biotech are down by 41%. However, the healthcare company still has some fans on Wall Street. Cathie Wood ...
Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that the company plans to release its second quarter 2024 financial results after the close of the U.S. financial markets on July 31, 2024. Following the release, company management w...